Black Friday Sale - Ends Soon!
-35% Off Everything
BeiGene, Ltd. (BGNE)
Last Price$215.04.3%
Market Cap$21.5B
BGNE overview
Crunching data... Almost there!
1W 12.9%
1M (0.7%)
6M 42.1%
YTD 21.5%
1Y 17.4%
3Y (37.4%)
5Y 5.8%
10Y 659.2%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
BGNE key stats
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!
BGNE Intrinsic value
BGNE Intrinsic value overview
BGNE Historical intrinsic value
BGNE Financials
BGNE Income statement
Crunching data... Almost there!
BGNE Balance sheet
Crunching data... Almost there!
BGNE Cash flow statement
Crunching data... Almost there!
BGNE Financial ratios
BGNE Growth
Crunching data... Almost there!
BGNE Returns on capital
Crunching data... Almost there!
Compare with peers: operational metrics
Growth & profitability
Solvency & returns
Crunching data... Almost there!
Wall Street estimates
Price target
Crunching data... Almost there!
Crunching data... Almost there!
EPS Surprises
Crunching data... Almost there!
Looking for the most undervalued companies?
Here's our top picks.
Crunching data... Almost there!
Discover more BGNE fundamentals
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
What is the Intrinsic Value of BeiGene, Ltd. (BGNE) stock?
As of today, intrinsic value of BeiGene, Ltd. is $268.7.
Is BeiGene, Ltd. (BGNE) stock undervalued or overvalued?
As of today, BeiGene, Ltd. is undervalued by 25.0%, compared to the current market share price of $215.0.
What is BeiGene, Ltd. (BGNE) stock rating?
As of today, BeiGene, Ltd. has a stock rating of 5 (out of 10), which is considered Good.
is BeiGene, Ltd. (BGNE) a good stock to buy?
As of today, BeiGene, Ltd. has a Good stock rating, which is 25.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.